Correspondence 

This section contains letters that have been sent by AABB on issues of concern to the transfusion medicine and cellular therapies communities.

Letter to The Joint Commission Regarding Proposed Blood Transfusion Service and Donor Center Standards  – 10/22/10
Letter From U.S. Rep. Van Hollen Urging CDC to Enhance Collaboration with Private Sector on Hemovigilance – 7/21/10 (PDF)
Letter to Congress Calling for Maintenance of Funding for Vector-Borne Diseases Program at CDC – 4/9/10
Memo to Members Regarding Technical Correction to the Circular of Information for the Use of Human Blood and Blood Components (August 2009) – 12/22/09
AABB Asks Test Manufacturers to Bring Additional HTLV–I/II Tests to the U.S. Market – 8/31/09 (PDF)
Letter to Facilities with ISBT 128 Variance – 7/16/09
Letter to Facilities with ISBT 128 Status Unknown – 7/16/09
Letter from CMS Clarifying MUE Policy – 4/14/09 (PDF)
Letter to HRSA on Specifications for Accreditation of Cord Blood Banks – 4/10/09
Response from the National Quality Forum Regarding the Definition of a Transfusion–Related Event – 3/5/09 (PDF)
Letter to the National Quality Forum Regarding the Definition of a Transfusion–Related Event – 2/12/09
Letter to FDA from the AABB Ad Hoc Task Force to Propose an Alternate Post–Market Study Design for Seven–Day Platelets – 4/28/08
FDA Response to Letter from AABB Bacterial Contamination Standard Task Force to FDA on Approval Strategies for Point–of–Release Testing for Bacterial Contamination – 4/24/08 (PDF)
Letter to the FDA Nominating Industry Representatives to BPAC – 2/28/08
Letter to the FDA on a Draft Template for a Shorter Inter–donation Interval During an Influenza Pandemic – 2/14/08
Follow up to the Letter from AABB Bacterial Contamination Standard Task Force to Gambro BCT and Fenwal in Response to the Discontinuation of the Passport Study – 2/13/08
Letter to FACT Proposing Accreditation Partnership – 2/4/08
Letter from AABB Bacterial Contamination Standard Task Force to Gambro BCT and Fenwal in Response to the Discontinuation of the Passport Study – 1/31/08
Letter from AABB Bacterial Contamination Standard Task Force to FDA on Approval Strategies for Point–of–Release Testing for Bacterial Contamination – 12/26/07
Letter to the AMA on Cord Blood Banking – 11/16/07
Letter to Verax Biomedical, Inc. Regarding the Platelet PGD® Test – 10/3/07 (PDF)
Letter to HHS on the Appointment of the Advisory Council on Blood Stem Cell Transplantation – 10/2/07
Letter to CMS Requesting Proper Categorization of the eBDS Test System – 9/14/07
Letter to FDA in Response to the Report of the Human Tissue Task Force – 7/6/07
Letter to Facilities Selected for Inclusion in 2007 NBCUS – 3/7/07 (PDF)